Multimodal Transformer-Based Fusion of Blood-Based and Digital Biomarkers for Explainable (XAI) Ultra-Early Alzheimer's Disease Detection

Multimodal Transformer-Based Fusion of Blood-Based and Digital Biomarkers for Explainable (XAI) Ultra-Early Alzheimer's Disease Detection

Alzheimer’s disease (AD) pathology develops years in advance prior to its clinical presentation. As a result, there is an urgent need to develop extremely early diagnosis modalities that are both accurate and feasible. Existing diagnosis methods based on CSF testing and/or amyloid and ta...